130 related articles for article (PubMed ID: 9142869)
1. Central opioid receptors mediate glucoprivic inhibition of pituitary LH secretion.
Briski KP
Am J Physiol; 1997 Apr; 272(4 Pt 1):E517-22. PubMed ID: 9142869
[TBL] [Abstract][Full Text] [Related]
2. Septopreoptic mu opioid receptor mediation of hindbrain glucoprivic inhibition of reproductive neuroendocrine function in the female rat.
Singh SR; Briski KP
Endocrinology; 2004 Nov; 145(11):5322-31. PubMed ID: 15308614
[TBL] [Abstract][Full Text] [Related]
3. Effects of mu and kappa opioid receptor antagonists on glucoprivic induction of Fos immunoreactivity in the rat preoptic area and hypothalamus.
Briski KP; Teodecki L
Brain Res Bull; 1999 Jun; 49(3):181-7. PubMed ID: 10435781
[TBL] [Abstract][Full Text] [Related]
4. CRF alters the infundibular LHRH secretory system from the medial preoptic area of female rats: possible involvement of opioid receptors.
Rivest S; Plotsky PM; Rivier C
Neuroendocrinology; 1993; 57(2):236-46. PubMed ID: 8389996
[TBL] [Abstract][Full Text] [Related]
5. Role of endogenous opioid peptides in central glucocorticoid receptor (GR)-induced decreases in circulating LH in the male rat.
Briski KP; Vogel KL
Neuropeptides; 1995 Mar; 28(3):175-81. PubMed ID: 7791961
[TBL] [Abstract][Full Text] [Related]
6. Selective alterations in macronutrient intake of food-deprived or glucoprivic rats by centrally-administered opioid receptor subtype antagonists in rats.
Koch JE; Bodnar RJ
Brain Res; 1994 Sep; 657(1-2):191-201. PubMed ID: 7820618
[TBL] [Abstract][Full Text] [Related]
7. Reduction by central beta-funaltrexamine of food intake in rats under freely-feeding, deprivation and glucoprivic conditions.
Arjune D; Standifer KM; Pasternak GW; Bodnar RJ
Brain Res; 1990 Dec; 535(1):101-9. PubMed ID: 1963340
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of suckling-induced prolactin release by mu- and kappa-opioid antagonists.
Baumann MH; Rabii J
Brain Res; 1991 Dec; 567(2):224-30. PubMed ID: 1667901
[TBL] [Abstract][Full Text] [Related]
9. Acute inhibition of pituitary LH release in the male rat by the glucocorticoid agonist decadron phosphate.
Briski KP; Sylvester PW
Neuroendocrinology; 1991 Oct; 54(4):313-20. PubMed ID: 1758573
[TBL] [Abstract][Full Text] [Related]
10. Central GABAA but not GABAB receptors mediate suppressive effects of caudal hindbrain glucoprivation on the luteinizing hormone surge in steroid-primed, ovariectomized female rats.
Singh SR; Briski KP
J Neuroendocrinol; 2005 Jul; 17(7):407-12. PubMed ID: 15946158
[TBL] [Abstract][Full Text] [Related]
11. Metabolic interfaces between growth and reproduction. V. Pulsatile luteinizing hormone secretion is dependent on glucose availability.
Bucholtz DC; Vidwans NM; Herbosa CG; Schillo KK; Foster DL
Endocrinology; 1996 Feb; 137(2):601-7. PubMed ID: 8593808
[TBL] [Abstract][Full Text] [Related]
12. Mode of action of interleukin-1 in suppression of pituitary LH release in castrated male rats.
Bonavera JJ; Kalra SP; Kalra PS
Brain Res; 1993 May; 612(1-2):1-8. PubMed ID: 8392427
[TBL] [Abstract][Full Text] [Related]
13. In vivo and in vitro studies on the opioidergic control of the secretion of gonadotrophin-releasing hormone and luteinizing hormone in sexually immature and adult male rats.
Leposavic G; Cover PO; Buckingham JC
Neuroendocrinology; 1991 Jun; 53(6):579-88. PubMed ID: 1652110
[TBL] [Abstract][Full Text] [Related]
14. Gonadotropin-releasing hormone-stimulated luteinizing hormone secretion by perifused pituitary cells from normal, gonadectomized, and testicular feminized rats.
Krieg RJ; Batson JM; Martha PM; Matt DW; Salisbury RL; Evans WS
Endocrinology; 1990 Jun; 126(6):3022-7. PubMed ID: 2190802
[TBL] [Abstract][Full Text] [Related]
15. Effect of intracerebroventricular beta-funaltrexamine on mu opioid receptors in the rat brain: consideration of binding condition.
Liu-Chen LY; Yang HH; Li S; Adams JU
J Pharmacol Exp Ther; 1995 Jun; 273(3):1047-56. PubMed ID: 7791074
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of luteinizing hormone release by morphine and endogenous opiates in cultured pituitary cells.
Blank MS; Fabbri A; Catt KJ; Dufau ML
Endocrinology; 1986 May; 118(5):2097-101. PubMed ID: 3009150
[TBL] [Abstract][Full Text] [Related]
17. Central, stereoselective receptors mediate the acute effects of opiate antagonists on luteinizing hormone secretion.
Blank MS; Mann DR; Daugherty DT; Sridiran R; Murphy JR
Life Sci; 1986 Oct; 39(17):1493-99. PubMed ID: 3020332
[TBL] [Abstract][Full Text] [Related]
18. Evidence that the inhibition of luteinizing hormone secretion exerted by central administration of neuropeptide Y (NPY) in the rat is predominantly mediated by the NPY-Y5 receptor subtype.
Raposinho PD; Broqua P; Pierroz DD; Hayward A; Dumont Y; Quirion R; Junien JL; Aubert ML
Endocrinology; 1999 Sep; 140(9):4046-55. PubMed ID: 10465275
[TBL] [Abstract][Full Text] [Related]
19. Inhibitory effects of endotoxin on LH secretion in the ovariectomized monkey are prevented by naloxone but not by an interleukin-1 receptor antagonist.
Xiao E; Xia-Zhang L; Ferin M
Neuroimmunomodulation; 2000; 7(1):6-15. PubMed ID: 10601814
[TBL] [Abstract][Full Text] [Related]
20. Evidence that stimulation of two modalities of pituitary luteinizing hormone release in ovarian steroid-primed ovariectomized rats may involve neuropeptide Y Y1 and Y4 receptors.
Jain MR; Pu S; Kalra PS; Kalra SP
Endocrinology; 1999 Nov; 140(11):5171-7. PubMed ID: 10537146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
